It is important to note that almost any phase 1 has nothing to do with efficacy and is merely that the drug is safe in healthy subjects. This is still very important and big news in this case as the antibiotic class isn’t new and has been shown to be effective in other configurations, it’s toxicity has been what has prevented it’s use in the past.